Goal Management Training for Adolescents with ADHD: A Multi-Center Randomized Controlled Effectiveness Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Non-pharmacological interventions targeting executive functions (EF), such as Goal Management Training (GMT), may augment treatment as usual (TAU) for adolescents with attention-deficit/hyperactivity disorder (ADHD). We examined whether GMT plus TAU improves EF, ADHD symptoms, and functional impairment more than TAU only. In this preregistered multi-center randomized controlled trial, 116 participants (M age = 14.69 years; 66% female) were randomized to GMT plus TAU or TAU only. GMT comprised seven weekly 2-hour group sessions, supplemented by parent and teacher sessions. TAU was standard outpatient mental health services. Outcomes were assessed at baseline and after 12 weeks. The primary outcome was the parent-reported Behavior Rating Inventory of Executive Function (BRIEF-2), Global Executive Composite (GEC). Secondary outcomes were teacher-, self-, and parent-reported BRIEF-2 subdomains; parent- and teacher-reported ADHD Rating Scale-IV scores; and parent-reported functional impairment measured with the Weiss Functional Impairment Rating Scale–Parent Report (WFIRS-P). GMT plus TAU showed no additional benefit over TAU only. Intention-to-treat analyses showed no significant between-group difference in GEC (adjusted b = − 2.12, 95% CI [− 7.64, 3.41], p = .449, d = − 0.14), parent-reported ADHD symptoms ( d = − 0.27, p = .323) or other secondary outcomes (all p > .10). Trial registration: ClinicalTrials.gov (NCT05874791; registered April 14, 2023).
Authors: Agnete Dyresen, Jan Stubberud, Krister Westlye Fjermestad, Anne Myge Gulsrud, Anne Benedicte Skirbekk, Ingvild Haugen, Merete Glenne Øie
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,990
OpenAlex ID: W7111861933
